Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» New GSK diabetes drug works, but faces tough competition
New GSK diabetes drug works, but faces tough competition
New GSK diabetes drug works, but faces tough competition
Submitted by
admin
on June 24, 2013 - 10:28am
Source:
Reuters
News Tags:
GSK
diabetes
albiglutide
GLP-1 agonist
Victoza
Byetta
Bydureon
Novo Nordisk
Bristol-Myers Squibb
AstraZeneca
Headline:
New GSK diabetes drug works, but faces tough competition
Do Not Allow Advertisers to Use My Personal information
